For citation:
Arinina E.E., Rashyd M.A. CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2012;5(3):41-46. (In Russ.)
Views: 315
Fullscreen
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Authors
Keywords
COPD
NAFLD
NASH
Pharmacoeconomics
budget impact analysis
chemotherapy
children
clinical and economic analysis
cost-effectiveness analysis
cost-utility analysis
direct costs
health technology assessment
indirect comparison
multiple myeloma
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
pharmacoeconomic analysis
pharmacoeconomic modeling
pharmacoeconomic studies
pharmacoeconomics
pharmacoepidemiology
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
